Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.

about

Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.

P2860

Q38677150-3489E769-81AC-4982-8815-CB921C7DBF60

P2860

Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.

Item

http://www.wikidata.org/entity/Q40316547

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ledipasvir/sofosbuvir is effec ...... ith chronic hepatitis C virus.

@en

type

Item

label

Ledipasvir/sofosbuvir is effec ...... ith chronic hepatitis C virus.

@en

prefLabel

Ledipasvir/sofosbuvir is effec ...... ith chronic hepatitis C virus.

@en

P1476

Ledipasvir/sofosbuvir is effec ...... ith chronic hepatitis C virus.

@en

P2093

Alexander Lalos

http://www.w3.org/2001/XMLSchema#string

Amber Tierney

http://www.w3.org/2001/XMLSchema#string

Coleman Smith

http://www.w3.org/2001/XMLSchema#string

Luz Liriano-Ward

http://www.w3.org/2001/XMLSchema#string

Michelle Sang

http://www.w3.org/2001/XMLSchema#string

Mohamed Hassan

http://www.w3.org/2001/XMLSchema#string

Rohit Satoskar

http://www.w3.org/2001/XMLSchema#string

Thomas Schiano

http://www.w3.org/2001/XMLSchema#string

P2860

Telaprevir for previously untreated chronic hepatitis C virus infection

Boceprevir for untreated chronic HCV genotype 1 infection

Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis.

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

Renal disease associated with hepatitis C infection after kidney and liver transplantation.

Effect of kidney transplantation on outcomes among patients with hepatitis C

Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies.

The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Hepatitis C virus and kidney disease.

P31

scholarly article

P356

10.1111/CTR.12941

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vinay Nair

Amilcar L Morales

P577

2017-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28239909

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.

about

P2860

P2860

Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921